Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

NCT07593092 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: XmAb541
BIOLOGICAL: XmAb808

Sponsor

Xencor, Inc.